What are the Historical Developments and Current Growth Metrics of the Hepatitis Diagnostic Tests Market?
The hepatitis diagnostic tests market has seen considerable growth due to a variety of factors.
• Over the past few years, the market size for hepatitis diagnostic tests has significantly expanded. Its growth is expected to continue, increasing from $4.64 billion in 2024 to $4.95 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.5%.
The sizeable growth in the past period can be credited to factors such as the global expansion of healthcare, governmental initiatives, a high disease burden, enhanced blood safety measures, and public health awareness campaigns.
What Does Future Hold for The Hepatitis Diagnostic Tests Market By 2029?
The hepatitis diagnostic tests market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the hepatitis diagnostic tests market is set to witness robust growth, with its value expected to reach $6.24 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.0%.
Factors such as international health safety concerns, population expansion and urbanization, customized testing approaches, focus on eradication programs and increased healthcare expenditure can be credited for the market growth in the forecast period. The period is also likely to see trends such as progress in testing technologies, combined testing for various hepatitis viruses, incorporation of molecular diagnostics, digital health interventions, and strategic alliances and partnerships.
What Are The Primary Growth Drivers In The Hepatitis Diagnostic Tests Market?
The increasing incidence of blood transfusions and donations is projected to drive the growth of the hepatitis diagnostic test market in the future. Blood transfusions and donations are interdependent processes where individuals voluntarily donate their blood, which in turn gets gathered, checked, and subsequently given to patients requiring additional blood components due to health issues or the loss of blood from surgical procedures, accidents, or illnesses. Hepatitis diagnostic tests are utilized to rigorously screen blood prior to donation or transfusion to safeguard patients. For example, in August 2023 as per the Royal College of Pathologists, a UK-based organization, the most common procedure for hospitalized patients was blood transfusion, with roughly 2 million blood components dispensed and transfused yearly in England at a cost exceeding £300 ($390.69) million. Hence, the growing count of blood transfusions and donations fuels the hepatitis diagnostic test market. The uptick in hepatitis cases is set to propel the hepatitis diagnostic tests market growth in the future. Hepatitis, medically known as inflammation of the liver, is a condition marked by the swelling and irritation of liver tissues, leading to multiple symptoms and health issues. Tests diagnosing hepatitis are of utmost importance in detecting and verifying the presence of hepatitis infections, allowing prompt and resourceful handling of these diseases. For example, the Hepatitis B Foundation, a US-based organization, reported that nearly 1.5 million people become newly infected with hepatitis annually in 2023. Consequently, the surge in hepatitis cases accelerates the hepatitis diagnostic tests market.
What Is The Segmentation Of The Global Hepatitis Diagnostic Tests Market?
The hepatitis diagnostic tests market covered in this report is segmented –
1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies
3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users
Subsegments:
1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)
3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy
Pre-Book The Hepatitis Diagnostic Tests Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Hepatitis Diagnostic Tests Market?
Leading firms in the hepatitis diagnostic test market are channeling their resources into the development of advanced automated immunoassays, such as Elecsys HCV Duo. These innovative devices, by employing automation and specialized equipment, carry out an array of functions in the immunoassay process, like sample handling, reagent mixing, detection, incubation, and result computation. For example, Roche Diagnostics India, a prominent biotechnological research firm based in India, introduced Elecsys HCV Duo in July 2023. This standout product, the first fully automated commercial immunoassay in the country, enables the concurrent and individual quantification of hepatitis C virus (HCV) antigen and antibody from a single plasma or serum sample from humans. It not only facilitates testing with a single specimen but also simplifies the diagnostic process. Thus, making repeat visits for additional tests unnecessary and easing the load on the healthcare system.
Who Are the Key Players In The Hepatitis Diagnostic Tests Market?
Major companies operating in the hepatitis diagnostic tests market report are:
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Roche Diagnostics
• Quest Diagnostics Incorporated
• Grifols S.A
• Hologic Inc.
• BioMérieux SA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• SD Biosensor Co. Ltd.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Randox Laboratories Ltd.
• Luminex Corporation
• Fujirebio Diagnostics Inc.
• Trivitron Healthcare Private Limited
• Trinity Biotech PLC
• MP Biomedicals LLC
• R-Biopharm AG
• Creative Diagnostics
• InBios International Inc.
• Dia.Pro Diagnostic Bioprobes srl
• DIALAB GmbH
What Are The Regional Insights Into The Hepatitis Diagnostic Tests Market?
North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
